Wuxi Pharmatech Earnings Preview: Can This Streak Continue?
Wuxi Pharmatech (NYSE:WX) will report earnings after markets close on Monday, May 13th. WuXi PharmaTech (Cayman) Inc. provides pharmaceutical and biotechnology research and development outsourcing. The Company’s services include discovery chemistry, service biology, analytical, pharmaceutical development, and manufacturing.
Here is your Cheat Sheet to Wuxi Pharmatech (cayman) Earnings:
Earnings Expectations: Analysts expect earnings of $0.31 per share on revenues of $130.02 million. Currently, the company’s P/E ratio stands at 16.32.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.34 to a profit $0.36. For the current year, the average estimate is a profit of $1.47, which is better than the estimate ninety days ago.
Here’s how Wuxi Pharmatech (cayman) has been performing on an annual basis:
|Revenue ($) in millions||253.48||270.02||334.06||407.18||499.91|
|Diluted EPS ($)||-1.04||0.72||1.20||1.04||1.20|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||108.54||118.03||130.38||125.84||125.66|
|Diluted EPS ($)||0.3102||0.28||0.2808||0.30||0.3323|
Wuxi Pharmatech (cayman) has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)